Cargando…

Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review)

As the major cause of irreversible loss of vision in adults, diabetic retinopathy (DR) is one of the most serious complications of diabetes. The imbalance of the retinal microenvironment and destruction of the blood-retinal barrier have a significant role in the progression of DR. Inward rectifying...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoyu, Lv, Jiajun, Li, Jiazhi, Ren, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343704/
https://www.ncbi.nlm.nih.gov/pubmed/34373707
http://dx.doi.org/10.3892/etm.2021.10453
_version_ 1783734340076699648
author Li, Xiaoyu
Lv, Jiajun
Li, Jiazhi
Ren, Xiang
author_facet Li, Xiaoyu
Lv, Jiajun
Li, Jiazhi
Ren, Xiang
author_sort Li, Xiaoyu
collection PubMed
description As the major cause of irreversible loss of vision in adults, diabetic retinopathy (DR) is one of the most serious complications of diabetes. The imbalance of the retinal microenvironment and destruction of the blood-retinal barrier have a significant role in the progression of DR. Inward rectifying potassium channel 4.1 (Kir4.1) is located on Müller cells and is closely related to potassium homeostasis, water balance and glutamate clearance in the whole retina. The present review discusses the functions of Kir4.1 in regulating the retinal microenvironment and related biological mechanisms in DR. In the future, Kir4.1 may represent a novel alternative therapeutic target for DR through affecting the retinal microenvironment.
format Online
Article
Text
id pubmed-8343704
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-83437042021-08-08 Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review) Li, Xiaoyu Lv, Jiajun Li, Jiazhi Ren, Xiang Exp Ther Med Review As the major cause of irreversible loss of vision in adults, diabetic retinopathy (DR) is one of the most serious complications of diabetes. The imbalance of the retinal microenvironment and destruction of the blood-retinal barrier have a significant role in the progression of DR. Inward rectifying potassium channel 4.1 (Kir4.1) is located on Müller cells and is closely related to potassium homeostasis, water balance and glutamate clearance in the whole retina. The present review discusses the functions of Kir4.1 in regulating the retinal microenvironment and related biological mechanisms in DR. In the future, Kir4.1 may represent a novel alternative therapeutic target for DR through affecting the retinal microenvironment. D.A. Spandidos 2021-09 2021-07-15 /pmc/articles/PMC8343704/ /pubmed/34373707 http://dx.doi.org/10.3892/etm.2021.10453 Text en Copyright: © Li et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Review
Li, Xiaoyu
Lv, Jiajun
Li, Jiazhi
Ren, Xiang
Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review)
title Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review)
title_full Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review)
title_fullStr Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review)
title_full_unstemmed Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review)
title_short Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review)
title_sort kir4.1 may represent a novel therapeutic target for diabetic retinopathy (review)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343704/
https://www.ncbi.nlm.nih.gov/pubmed/34373707
http://dx.doi.org/10.3892/etm.2021.10453
work_keys_str_mv AT lixiaoyu kir41mayrepresentanoveltherapeutictargetfordiabeticretinopathyreview
AT lvjiajun kir41mayrepresentanoveltherapeutictargetfordiabeticretinopathyreview
AT lijiazhi kir41mayrepresentanoveltherapeutictargetfordiabeticretinopathyreview
AT renxiang kir41mayrepresentanoveltherapeutictargetfordiabeticretinopathyreview